US Stock MarketDetailed Quotes

SNOA Sonoma Pharmaceuticals

Watchlist
  • 0.3371
  • -0.0897-21.02%
Close Jul 18 16:00 ET
6.41MMarket Cap-636P/E (TTM)

Sonoma Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
(Q2)Sep 30, 2022
(Q1)Jun 30, 2022
Total revenue
-4.05%12.74M
14.10%3.44M
6.59%3.14M
-18.01%2.73M
-13.96%3.43M
5.10%13.27M
31.16%3.01M
1.45%2.94M
-11.03%3.33M
8.12%3.98M
Operating revenue
-4.05%12.74M
14.10%3.44M
6.59%3.14M
-18.01%2.73M
-13.96%3.43M
5.10%13.27M
31.16%3.01M
1.45%2.94M
-11.03%3.33M
8.12%3.98M
Cost of revenue
-9.15%7.99M
9.21%2.35M
-20.59%1.68M
-3.01%1.74M
-4.88%2.22M
1.85%8.8M
-2.36%2.15M
24.37%2.11M
-28.29%1.8M
4.75%2.34M
Gross profit
5.99%4.75M
26.27%1.09M
75.69%1.46M
-35.55%990K
-26.85%1.2M
12.12%4.48M
800.00%864K
-30.92%831K
23.77%1.54M
13.28%1.65M
Operating expense
4.41%9.45M
24.32%2.5M
-13.55%2.3M
-3.04%2.2M
-2.28%2.44M
-8.43%9.05M
-36.28%2.01M
23.32%2.67M
2.81%2.27M
6.11%2.5M
Selling and administrative expenses
-14.31%7.58M
15.52%2.09M
-36.10%1.7M
-19.59%1.66M
-7.67%2.12M
-9.38%8.84M
-42.58%1.81M
24.82%2.67M
-5.83%2.07M
0.97%2.3M
Research and development costs
803.86%1.87M
103.48%409K
--601K
168.00%536K
57.77%325K
65.60%207K
4,925.00%201K
--0
1,900.00%200K
145.24%206K
Operating profit
-2.87%-4.7M
-22.84%-1.41M
53.98%-844K
-65.25%-1.21M
-45.03%-1.24M
22.37%-4.57M
62.52%-1.15M
-91.44%-1.83M
24.17%-731K
5.42%-855K
Net non-operating interest income expense
Other net income (expense)
46.25%-330K
117.12%50K
-11.27%-79K
51.61%-90K
-214.93%-211K
-228.18%-614K
-37.09%-292K
-745.45%-71K
-121.31%-186K
65.28%-67K
Other non- operating income (expenses)
46.25%-330K
117.12%50K
-11.27%-79K
51.61%-90K
-214.93%-211K
-55.84%-614K
68.80%-292K
-745.45%-71K
-125.73%-186K
65.28%-67K
Income before tax
2.95%-5.03M
5.56%-1.36M
51.55%-923K
-41.55%-1.3M
-57.38%-1.45M
4.32%-5.18M
56.15%-1.44M
-101.80%-1.91M
-865.26%-917K
16.03%-922K
Income tax
-493.94%-196K
-122.90%-292K
-267.65%-57K
86.00%186K
5.71%-33K
90.06%-33K
61.24%-131K
34K
1,900.00%100K
-35K
Net income
6.13%-4.84M
18.43%-1.07M
55.34%-866K
-45.92%-1.48M
-59.86%-1.42M
-1.28%-5.15M
55.57%-1.31M
-105.40%-1.94M
-917.00%-1.02M
19.22%-887K
Net income continuous Operations
6.13%-4.84M
18.43%-1.07M
55.34%-866K
-45.92%-1.48M
-59.86%-1.42M
-1.28%-5.15M
55.57%-1.31M
-105.40%-1.94M
-917.00%-1.02M
19.22%-887K
Minority interest income
Net income attributable to the parent company
6.13%-4.84M
18.43%-1.07M
55.34%-866K
-45.92%-1.48M
-59.86%-1.42M
-1.28%-5.15M
55.57%-1.31M
-105.40%-1.94M
-917.00%-1.02M
19.22%-887K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
6.13%-4.84M
18.43%-1.07M
55.34%-866K
-45.92%-1.48M
-59.86%-1.42M
-1.28%-5.15M
55.57%-1.31M
-105.40%-1.94M
-917.00%-1.02M
19.22%-887K
Basic earnings per share
65.13%-0.53
75.58%-0.0684
87.10%-0.08
12.12%-0.29
0.00%-0.29
20.83%-1.52
73.83%-0.28
-100.00%-0.62
-725.00%-0.33
44.23%-0.29
Diluted earnings per share
65.13%-0.53
75.58%-0.0684
87.10%-0.08
12.12%-0.29
0.00%-0.29
20.83%-1.52
73.83%-0.28
-100.00%-0.62
-725.00%-0.33
44.23%-0.29
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022(Q2)Sep 30, 2022(Q1)Jun 30, 2022
Total revenue -4.05%12.74M14.10%3.44M6.59%3.14M-18.01%2.73M-13.96%3.43M5.10%13.27M31.16%3.01M1.45%2.94M-11.03%3.33M8.12%3.98M
Operating revenue -4.05%12.74M14.10%3.44M6.59%3.14M-18.01%2.73M-13.96%3.43M5.10%13.27M31.16%3.01M1.45%2.94M-11.03%3.33M8.12%3.98M
Cost of revenue -9.15%7.99M9.21%2.35M-20.59%1.68M-3.01%1.74M-4.88%2.22M1.85%8.8M-2.36%2.15M24.37%2.11M-28.29%1.8M4.75%2.34M
Gross profit 5.99%4.75M26.27%1.09M75.69%1.46M-35.55%990K-26.85%1.2M12.12%4.48M800.00%864K-30.92%831K23.77%1.54M13.28%1.65M
Operating expense 4.41%9.45M24.32%2.5M-13.55%2.3M-3.04%2.2M-2.28%2.44M-8.43%9.05M-36.28%2.01M23.32%2.67M2.81%2.27M6.11%2.5M
Selling and administrative expenses -14.31%7.58M15.52%2.09M-36.10%1.7M-19.59%1.66M-7.67%2.12M-9.38%8.84M-42.58%1.81M24.82%2.67M-5.83%2.07M0.97%2.3M
Research and development costs 803.86%1.87M103.48%409K--601K168.00%536K57.77%325K65.60%207K4,925.00%201K--01,900.00%200K145.24%206K
Operating profit -2.87%-4.7M-22.84%-1.41M53.98%-844K-65.25%-1.21M-45.03%-1.24M22.37%-4.57M62.52%-1.15M-91.44%-1.83M24.17%-731K5.42%-855K
Net non-operating interest income expense
Other net income (expense) 46.25%-330K117.12%50K-11.27%-79K51.61%-90K-214.93%-211K-228.18%-614K-37.09%-292K-745.45%-71K-121.31%-186K65.28%-67K
Other non- operating income (expenses) 46.25%-330K117.12%50K-11.27%-79K51.61%-90K-214.93%-211K-55.84%-614K68.80%-292K-745.45%-71K-125.73%-186K65.28%-67K
Income before tax 2.95%-5.03M5.56%-1.36M51.55%-923K-41.55%-1.3M-57.38%-1.45M4.32%-5.18M56.15%-1.44M-101.80%-1.91M-865.26%-917K16.03%-922K
Income tax -493.94%-196K-122.90%-292K-267.65%-57K86.00%186K5.71%-33K90.06%-33K61.24%-131K34K1,900.00%100K-35K
Net income 6.13%-4.84M18.43%-1.07M55.34%-866K-45.92%-1.48M-59.86%-1.42M-1.28%-5.15M55.57%-1.31M-105.40%-1.94M-917.00%-1.02M19.22%-887K
Net income continuous Operations 6.13%-4.84M18.43%-1.07M55.34%-866K-45.92%-1.48M-59.86%-1.42M-1.28%-5.15M55.57%-1.31M-105.40%-1.94M-917.00%-1.02M19.22%-887K
Minority interest income
Net income attributable to the parent company 6.13%-4.84M18.43%-1.07M55.34%-866K-45.92%-1.48M-59.86%-1.42M-1.28%-5.15M55.57%-1.31M-105.40%-1.94M-917.00%-1.02M19.22%-887K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 6.13%-4.84M18.43%-1.07M55.34%-866K-45.92%-1.48M-59.86%-1.42M-1.28%-5.15M55.57%-1.31M-105.40%-1.94M-917.00%-1.02M19.22%-887K
Basic earnings per share 65.13%-0.5375.58%-0.068487.10%-0.0812.12%-0.290.00%-0.2920.83%-1.5273.83%-0.28-100.00%-0.62-725.00%-0.3344.23%-0.29
Diluted earnings per share 65.13%-0.5375.58%-0.068487.10%-0.0812.12%-0.290.00%-0.2920.83%-1.5273.83%-0.28-100.00%-0.62-725.00%-0.3344.23%-0.29
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg